Echinacea (Echinacea)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspPills.
Composition:
Active component:
Echinacea. extract, dry with the content of the sum of the derivatives of oxycinnamic acids in, converted to chicory acid 7% - 0.2 g
Auxiliary substances:
Sugar, milk> -0,190g,, (lactose monohydrate)
Potato starch - 0.100 g
Polyvinylpyrrolidone 0.005 g
low molecular weight medical (povidone)
Calcium stearate - 0.005 g
Weight of a tablet - 0,5 g

Description:Tablets are round biconvex with a risk from light brown to dark brown with lighter and darker patches.
Pharmacotherapeutic group:Immunostimulating agent of plant origin
ATX: & nbsp
    • Pharmacodynamics:
    The main active ingredients of the drug are. derivatives of oxycinnamic acids (mainly chicory acid), polysaccharides, isobutyl amides and glycoproteins. Echinacea stimulates the activity of the cellular and humoral links of the immune system. The drug increases the phagocytic activity of neutrophils and macrophages, potentiates the production of interleukin-1 by macrophages, induces a transformation.
    B-lymphocytes into plasma cells, enhances antibody formation,
    cooperation of B- and T-lymphocytes, T-helper activity.

    Pharmacokinetics:No data available
    Indications:Treatment and prevention of diseases accompanied by immunodeficiency states, including,chronic recurrent inflammatory diseases (chronic bronchitis, pneumonia, ENT diseases) with inefficiency or insufficient effectiveness of antibacterial and anti-inflammatory therapy.
    Contraindications:
    Increased individual sensitivity to the components of the drug, progressive systemic diseases (tuberculosis, leukemia, collagenosis, rheumatism, multiple sclerosis, AIDS, HIV infection, autoimmune diseases, widespread atherosclerosis), congenital intolerance to galactose, deficiency of lactase Lappa, glucose-galactose malabsorption. The drug is not recommended for use in children under the age of 18 due to lack of data on efficacy and safety.
    Carefully:
    Patients with diabetes mellitus and those on a diet with a reduced carbohydrate content.
    If you have any of these diseases, consult a doctor before taking the drug.
    Pregnancy and lactation:
    Application during pregnancy and, during breastfeeding is possible only after consulting a doctor.
    Dosing and Administration:
    Inside, adults 1-2 tablets 3 times a day after meals.
    In the phase of exacerbation. The drug is prescribed in combination with antibacterial therapy 2 tablets 3 times a day for 5 days, then 1 tablet 3 times a day for 10 to 20 days, depending on the nature and severity of the disease.
    In the phase of remission appoint 1-2 tablets 3 times a day for 10-20 days. If necessary, the course of treatment can be repeated after 2-3 weeks.

    Side effects:
    Allergic reactions (skin hyperemia, skin rash, face swelling), shortness of breath, sweating, lowering of blood pressure.
    If any of the side effects indicated in the manual are aggravated, or you notice any other side effects not listed in the instructions, tell your doctor.
    Overdose:So far, no cases of overdose have been reported.
    Interaction:It is possible to use simultaneously with antibiotics and other antimicrobial drugs. Incompatible with immunosuppressants.
    Special instructions:
    Patients with diabetes should take into account that one tablet of the drug contains about 0.29 grams of carbohydrates (0.024 XE).
    Effect on the ability to drive transp. cf. and fur:The use of the drug does not affect the performance of potentially hazardous activities requiring special attention and quick reactions (vehicle management, working with moving mechanisms, dispatcher and operator work, etc.).
    Form release / dosage:Tablets 200 mg.
    Packaging:For 10 tablets in a planar cell package. 1, 2 or 3 contour mesh packages together with instructions for use in a pack of cardboard.
    Storage conditions:
    In a dry, protected from light place at a temperature of no higher than 25 ° C.
    Keep out of the reach of children.
    Shelf life:
    2 years.
    Do not use after the expiration date.
    Terms of leave from pharmacies:On prescription
    Registration number:P N003884 / 01
    Date of registration:12.01.2010
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp20.02.2016
    Illustrated instructions
      Instructions
      Up